Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/27/2012WO2012129017A1 Peritoneal dialysis solutions comprising glucose polymers
09/27/2012WO2012129014A1 Piperidine carboxamide spirohydantoin cgrp receptor antagonists
09/27/2012WO2012128982A2 Compositions and methods useful for ameliorating age related maladies
09/27/2012WO2012128780A1 Compounds and processes that generate cyclopropenes and substtituted cyclopropenes on demand
09/27/2012WO2012128734A1 Methods and compositions for the generation of peracetic acid on site at the point-of-use
09/27/2012WO2012128709A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof.
09/27/2012WO2012128689A1 Treatment of solid tumours
09/27/2012WO2012128653A1 Use of anastrozole and vitamin d analogue in the combined therapy of breast cancer
09/27/2012WO2012128587A2 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
09/27/2012WO2012128582A2 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
09/27/2012WO2012128576A2 Composition for treating lower or damaged cognitive function containing dehydroglyasperin c typically found in licorice
09/27/2012WO2012128530A2 2-methyl-2-alkyl-6-amido-2h-benzopyran derivatives having anti-cancer activity
09/27/2012WO2012128521A2 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor
09/27/2012WO2012128501A2 Pharmaceutical composition containing, as an active ingredient, m-3m3fbs, which is an activator of phospholipase c, for preventing or treating inflammatory diseases or infectious diseases
09/27/2012WO2012128496A2 Pharmaceutical composition for preventing or treating asthma containing maackiain as an active ingredient
09/27/2012WO2012128417A1 Water-soluble cationic-drug delivery system having a sustained-release mechanism
09/27/2012WO2012128394A1 A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
09/27/2012WO2012128326A1 Nanoparticles for photo dynamic therapy
09/27/2012WO2012127984A1 Marker for determination of sensitivity to anticancer agent
09/27/2012WO2012127927A1 Medical device for controlled release of drug
09/27/2012WO2012127885A1 Tetrahydrocarboline derivative
09/27/2012WO2012127878A1 A 5-ht4 receptor agonist as a prokinetic agent
09/27/2012WO2012127871A1 Combination medicine for treatment of depression
09/27/2012WO2012127739A1 Novel carrier molecule and method both for delivering rna into cytoplasm using near-infrared light
09/27/2012WO2012127506A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012WO2012127497A1 Stable pharmaceutical compositions of ketorolac or salts thereof
09/27/2012WO2012127485A1 A novel process for preparation of polysaccharides
09/27/2012WO2012127483A1 Processes for the preparation of intermediates of n-[2-(7-methoxy-1-naphthyl) ethyl] acetamide
09/27/2012WO2012127466A1 5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
09/27/2012WO2012127441A1 Treatment of proliferative disorders with a chemiluminescent agent
09/27/2012WO2012127431A1 Stabilized compositions of tetrahydrobiopterin
09/27/2012WO2012127407A1 Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid
09/27/2012WO2012127393A1 COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
09/27/2012WO2012127388A1 Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012WO2012127385A1 Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators
09/27/2012WO2012127302A1 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
09/27/2012WO2012127277A2 Bendamustine anionic-catioinic cyclopolysaccharide compositions
09/27/2012WO2012127214A1 Quinolinone derivatives for use in the treatment of an autoimmune disease and/or an inflammatory disease
09/27/2012WO2012127212A1 Imidazo [1, 2 - b] pyridazine derivatives as cdpk1 inhibitors
09/27/2012WO2012127176A1 Derivatives of allopregnanolone and of epiallopregnanolone and uses thereof for treating a neuropathological condition
09/27/2012WO2012127048A1 Solid pharmaceutical composition comprising donepezil
09/27/2012WO2012127041A1 Method of screening antiretroviral compounds and vaccine
09/27/2012WO2012127037A2 A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
09/27/2012WO2012127032A1 Novel pyrimidine derivatives
09/27/2012WO2012127030A1 Arylpiperazines as neuroprotective agents
09/27/2012WO2012127009A1 Compositions containing polymeric, ionic compounds comprising imidazolium groups
09/27/2012WO2012126984A1 Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012WO2012126899A2 Inhibition and treatment of biofilms
09/27/2012WO2012126813A1 Solid ambroxol-containing preparation
09/27/2012WO2012126791A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/27/2012WO2012126777A1 Inhibition of neuraminidase activity
09/27/2012WO2012126770A1 Doxylamine resinate complex
09/27/2012WO2012126472A1 Gaba-c receptor agonists or antagonists for use in the treatment of vascular diseases
09/27/2012WO2012126390A1 Autophagy inducing compound and use thereof
09/27/2012WO2012126386A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126385A1 New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126369A1 Dna, recombinant vector containing the same, cell, composition and use thereof
09/27/2012WO2012126280A1 Rutaecarpine compound, preparation method therefor, and use thereof
09/27/2012WO2012126278A1 Terbinafine reverse thermo-sensitive reversible aquagel composition
09/27/2012WO2012126275A1 Spiro-containing dihydropyrazole compounds
09/27/2012WO2012126231A1 Use of poly(4-styrene sulfonic acid-copoly-maleic acid) sodium salt and pharmaceutical composition thereof
09/27/2012WO2012126198A1 Acid-base neutralizing solution for chemical burning protection
09/27/2012WO2012126181A1 Use of kinase inhibitors in preventing and treating inflammatory disorder
09/27/2012WO2012126091A1 Selective glycosidase inhibitors and uses thereof
09/27/2012WO2012126084A1 Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections
09/27/2012WO2012106287A3 Methods of treating acute kidney injury with retinoc acid
09/27/2012WO2012105887A8 Active principle for mitigating undesired medical conditions
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012WO2012103398A9 Methods for treating obstructive sleep apnea
09/27/2012WO2012100017A3 Antiretroviral cyclonucleoside compositions and methods and articles of manufacture therewith
09/27/2012WO2012099962A3 Pharmaceutical compositions and methods for making and using them
09/27/2012WO2012099785A3 Modulators of tlr3/dsrna complex and uses thereof
09/27/2012WO2012087257A3 Oral dosage form comprising imatinib and production of said oral dosage form
09/27/2012WO2012087256A3 Pharmaceutical capsule formulations
09/27/2012WO2012078586A3 Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer
09/27/2012WO2012078525A3 Compositions and methods for treating ophthalmic conditions
09/27/2012WO2012078416A3 Monophosphate prodrugs of dapd and analogs thereof
09/27/2012WO2012075244A3 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
09/27/2012WO2012074930A3 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
09/27/2012WO2012069658A4 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders
09/27/2012WO2012068339A3 Methods of treating cancer
09/27/2012WO2012068319A3 Method of treating hematological cancers
09/27/2012WO2012065963A3 Antiviral condensed heterocyclic compounds
09/27/2012WO2012064396A3 Novel ezrin inhibitors and methods of making and using
09/27/2012WO2012059598A3 Methods of treating rheumatoid arthritis using il-17 antagonists
09/27/2012WO2012059442A3 Neurotrypsin inhibitors
09/27/2012WO2012058269A3 Methods of treating cancer and other diseases
09/27/2012WO2012047907A9 Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
09/27/2012WO2012031298A3 Ethynylbenzene derivatives
09/27/2012WO2012030927A3 Modified-release dosage forms of 5-ht2c agonists useful for weight management
09/27/2012WO2012020848A8 Heterocyclic compound and use thereof
09/27/2012WO2012020214A3 Anti-microbial metal organic framework
09/27/2012WO2012019106A8 Compounds for use in modulating the nmda receptor
09/27/2012WO2011135520A8 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
09/27/2012WO2011112867A8 The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
09/27/2012US20120245703 Composite bone material implant and method
09/27/2012US20120245561 Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245540 Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 7860